Medications for Pulmonary Hypertension Due To Interstitial Lung Disease

1 result
  • tyvaso - treprostinil inhalant

    (Treprostinil)
    United Therapeutics Corporation
    Tyvaso treats pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) in adults to improve exercise ability.